Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Cocaine Use Disorder
NCT07086794Phase 1Recruiting
- Start
- Nov 2025
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of pentoxifylline in cocaine use disorder (CUD) (3 arms). Primary endpoint: Reinforcing Effects of Cocaine at 1 month. Started Nov 2025; status: recruiting.
02
Drugs
pentoxifylline
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NCT07086794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086794.